Tilray (TLRY) Projected to Post Earnings on Tuesday

Tilray (NASDAQ:TLRY - Get Free Report) will likely be announcing its earnings results before the market opens on Tuesday, April 8th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $213.38 million for the quarter. Tilray has set its FY 2025 guidance at EPS.

Tilray (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings results on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.07). The business had revenue of $210.90 million for the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. Tilray's quarterly revenue was up 8.7% on a year-over-year basis. On average, analysts expect Tilray to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Tilray Trading Down 4.2 %

Tilray stock traded down $0.03 during mid-day trading on Friday, hitting $0.59. The company's stock had a trading volume of 22,175,962 shares, compared to its average volume of 29,753,407. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54. The company has a 50 day moving average of $0.80 and a 200-day moving average of $1.23. Tilray has a one year low of $0.55 and a one year high of $2.77. The stock has a market cap of $555.28 million, a PE ratio of -1.97 and a beta of 1.88.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group raised their price target on shares of Tilray from $2.00 to $3.00 and gave the stock a "buy" rating in a research note on Monday, January 13th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $2.70.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.